Modern ideas about the pathogenesis of chronic urticaria. Effective treatments
- Authors: Svechnikova E.V.1,2, Zhufina S.E.1
-
Affiliations:
- Polyclinic № 1 of the Administrative Department of the President of the Russian Federation
- Russian Biotechnological University
- Issue: Vol 30, No 9/10 (2023)
- Pages: 198-202
- Section: Dermatology/allergology
- URL: https://journals.eco-vector.com/2073-4034/article/view/624940
- DOI: https://doi.org/10.18565/pharmateca.2023.9-10.198-202
- ID: 624940
Cite item
Open Access
Access granted
Abstract
The article focuses on the prevalence and pathogenesis of chronic urticaria, especially spontaneous. Research in these areas has led to significant progress in terms of recommendations for the treatment of pathology. New CIA (Collegium Internationale Allergologicum) data show that the prevalence of chronic urticaria is geographically heterogeneous, high in all age groups, especially in young and middle-aged patients, and there is an upward trend in incidence. Chronic urticaria disrupts performance capability, leads to a deterioration in the quality of life of patients. Several recent studies have clarified and characterized two endotypes of chronic spontaneous urticaria: autoimmune (or autoallergic) type I, driven by IgE to autoallergens, and type IIb, which is caused by autoantibodies targeting mast cells. The aim of studying the pathogenesis of chronic urticaria is development of recommendations for medical practitioners to facilitate and accelerate the diagnosis of chronic urticaria, to be able to control the disease and maintain long-term remission.
Full Text
About the authors
E. V. Svechnikova
Polyclinic № 1 of the Administrative Department of the President of the Russian Federation; Russian Biotechnological University
Author for correspondence.
Email: elene-elene@bk.ru
ORCID iD: 0000-0002-5885-4872
Dr. Sci. (Med.), Professor, Department of Skin and Venereal Diseases; Head of the Department of Dermatovenereology and Cosmetology
Russian Federation, Moscow; MoscowS. E. Zhufina
Polyclinic № 1 of the Administrative Department of the President of the Russian Federation
Email: elene-elene@bk.ru
ORCID iD: 0000-0001-5694-2847
Russian Federation, Moscow
References
- Клинические рекомендации. Крапивница. Российское общество дерматовенерологов и косметологов. Российская ассоциация аллергологов и клинических иммунологов. 2020 г. [Clinical recommendations. Urticaria. Russian Society of Dermatovenerologists and Cosmetologists. Russian Association of Allergists and Clinical Immunologists. 2020. (In Russ.)].
- Thomsen S.F., Pritzier E.C., Anderson C.D., et al. Chronic urticaria in the real-life clinical practice setting in Sweden, Norway and Denmark: baseline results from the non-interventional multicentre AWARE study. J Eur Acad Dermatol Venereol. 2017;31:1048–55. doi: 10.1111/jdv.14210.
- Tayefi М., et al. Chronic Urticaria: A Swedish Registry-based Cohort Study on Population, Comorbidities and Treatment Characteristics. Acta Derm Venereol. 2022;102:adv00624. doi: 10.2340/actadv.v101.737.
- Fricke J., Avila G., Keller T., et al. Prevalence of chronic urticaria in children and adults across the globe: systematic review with meta-analysis. Allergy. 2020;75(2):423–32. doi: 10.1111/all.14037.
- Sanchez-Borges M., Ansotegui I.J., et al. The challenges of chronic urticaria part 1: Epidemiology, immunopathogenesis, comor-bidities, quality of life, and management. World Allergy Organ J. 2021;14(6):100533. doi: 10.1016/j.waojou.2021.100533.
- Pozderac I., Lugović-Mihic L., et al. Chronic inducible urticaria: classification and prominent features of physical and non-physical types Acta Dermatovenerol. APA. 2020;29:141–48. doi: 10.15570/actaapa.2020.29.
- Zuberbier T., Aberer W., Asero R., et al. The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticarial Allergy. 2018;73(7):1393–414. doi: 10.1111/all.13397.
- Maurer M., Staubach P., Raap U., et al. H1-antihistamine-refractory chronic spontaneous urticaria: it’s worse than we thought – first results of the multicenter real-life AWARE study. Clin. Exp Allergy. 2017;47:684–92. doi: 10.1111/cea.12900.
- Bracken S.J., Abraham S., MacLeod A.S. Autoimmune Theories of Chronic Spontaneous Urticaria. Front Immunol. 201910:627. doi: 10.3389/fimmu.2019.00627.
- Kolkhir P., Borzova E., Grattan C., et al. Autoimmune comorbidity in chronic spontaneous urticaria: a systematic review. Autoimmun Rev. 2017;16:1196–208. doi: 10.1016/j.autrev.2017.10.003.
- Maurer M., Altrichter S., Schmetzer O., et al. Immunoglobulin E-mediated autoimmunity. Front Immunol. 2018;9:689. doi: 10.3389/fimmu.2018.00689.
- Schmetzer O., Lakin E., Topal F.A., et al. IL-24 is a common and specific autoantigen of IgE in patients with chronic spontaneous urticaria. J Allergy Clin Immunol. 2018;142:876–82. doi: 10.1016/j.jaci.2017.10.035.
- Maurer M., et al. Urticaria: Collegium Internationale Allergologicum (CIA) Update 2020. Int Arch. Allergy Immunol. 2020;181:321–33. doi: 10.1159/000507218.
- Balp M.M., Khalil S., Tian H., et al. Burden of chronic urticaria relative to psoriasis in five European countries. J Eur Acad Dermatol. Venereol. 2018;32(2): 282–90. doi: 10.1111/jdv.14584.
- Konstantinou G.N., Konstantinou G.N. Psychi- atric comorbidity in chronic urticaria pa- tients: a systematic review and meta-analysis. Clin Transl Allergy. 2019;9(1):42. doi: 10.1186/s13601-019-0278-3.
- Asero R., Marzano A.V., Ferrucci S., Cugno M. D-dimer plasma levels parallel the clinical response to omalizumab in patients with severe chronic spontaneous urticaria. Int Arch Allergy Immunol. 2017;172(1):40–4. Doi: 10.1159/ 000453453.
- Asero R. Serial D-dimer plasma levels in a patient with chronic spontaneous urticaria developing resistance to omalizumab. Clin Exp Dermatol. 2017;42(6):667–69. Doi: 10.1111/ ced.13181.
- Zhang Y., Zhang H., Du Sh., et al. Advanced Biomarkers: Therapeutic and Diagnostic Targets in Urticaria. Int Arch Allergy Immunol. 2021;182:917–931. doi: 10.1159/000515753.
Supplementary files
